World Clinical Drug
|
2023, 44(6): 649-652
• Pharmacy administration •
Analysis and prospect of supporting documents of various provinces in 'About deepening the review of the opinions of the examination and approval system reform to encourage pharmaceutical medical equipment innovation'
Full
Xinyu ZHANG1, Siming HUA2, Zhiyan LIU3, Meinan ZHAO1, Ling WANG1, Junlong WANG4, *, Jinpeng WANG5, *
Affiliations
- 1.Beijing Zhongguancun Enterprise Association of Biotech & Pharma, Beijing 100021, China
- 2.Sinopharm Group Beijing Huahong Co., Ltd., Beijing 100000, China
- 3.Department of Pharmacy, Peking University First Hospital, Beijing 100034, China
- 4.China State Institute of Pharmaceutical Industry Clinical Research Center, Shanghai 200437, China
- 5.China National Pharmaceutical Industry Co., Ltd., Beijing 101300, China
Published: 2023-06-10
doi: 10.13683/j.wph.2023.06.023
Outline
张馨予, 化思明, 刘志艳, 赵美楠, 王玲, 王俊龙, 王金鹏.
针对《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》各省市配套文件的分析与展望.
世界临床药物,
2023
, 44
(6)
: 649
-652
.
DOI: 10.13683/j.wph.2023.06.023
Xinyu ZHANG, Siming HUA, Zhiyan LIU, Meinan ZHAO, Ling WANG, Junlong WANG, Jinpeng WANG.
Analysis and prospect of supporting documents of various provinces in 'About deepening the review of the opinions of the examination and approval system reform to encourage pharmaceutical medical equipment innovation'[J].
World Clinical Drug,
2023
, 44
(6)
: 649
-652
.
DOI: 10.13683/j.wph.2023.06.023
Year 2023 volume 44 Issue 6
14
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.06.023
- Receive Date:2023-01-12
- Online Date:2026-11-18
- Published:2023-06-10